Evidence map›Paper›PMID 40329334›Full record

ArticleGenome medicine2025

Simultaneous detection of pathogens and antimicrobial resistance genes with the open source, cloud-based, CZ ID platform.

Dan Lu, Katrina L Kalantar, Abigail L Glascock, Victoria T Chu, Estella S Guerrero, Nina Bernick, Xochitl Butcher, Kirsty Ewing, Elizabeth Fahsbender, Olivia Holmes and 14 more

Abstract read
In one paragraph

Article in Genome medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Global Genomic Surveillance.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Metagenomic next-generation sequencing: new horizons in microbiology.Frontiers in cellular and infection microbiology · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Dan Lu *Chan Zuckerberg Initiative, Redwood City, CA, USA.
Katrina L Kalantar *Chan Zuckerberg Initiative, Redwood City, CA, USA.
Abigail L Glascock *Chan Zuckerberg Biohub, San Francisco, CA, USA.
Victoria T ChuChan Zuckerberg Biohub, San Francisco, CA, USA.
Estella S GuerreroNova Southeastern University, Fort Lauderdale, FL, USA.
Nina BernickChan Zuckerberg Initiative, Redwood City, CA, USA.
Xochitl ButcherChan Zuckerberg Initiative, Redwood City, CA, USA.
Kirsty EwingChan Zuckerberg Initiative, Redwood City, CA, USA.
Elizabeth FahsbenderChan Zuckerberg Initiative, Redwood City, CA, USA.
Olivia HolmesChan Zuckerberg Initiative, Redwood City, CA, USA.
Erin HoopsChan Zuckerberg Initiative, Redwood City, CA, USA.
Ann E JonesChan Zuckerberg Initiative, Redwood City, CA, USA.
Ryan LimChan Zuckerberg Initiative, Redwood City, CA, USA.
Suzette McCannyChan Zuckerberg Initiative, Redwood City, CA, USA.
Lucia ReynosoChan Zuckerberg Initiative, Redwood City, CA, USA.
Karyna RosarioChan Zuckerberg Initiative, Redwood City, CA, USA.
Jennifer TangChan Zuckerberg Initiative, Redwood City, CA, USA.
Omar ValenzuelaChan Zuckerberg Initiative, Redwood City, CA, USA.
Peter M MouraniDepartment of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Amy J PickeringChan Zuckerberg Biohub, San Francisco, CA, USA.
Amogelang R RaphenyaDepartment of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Brian P AlcockDepartment of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Andrew G McArthurDepartment of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Charles R LangelierChan Zuckerberg Biohub, San Francisco, CA, USA. chaz.langelier@czbiohub.org.

Funding

Integrated Host/Microbe Metagenomics to Improve Lower Respiratory Tract Infection Diagnosis in Critically Ill ChildrenR01HL155418 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANGELIER, CHARLES · 2021 to 2024
$1.6M
Metagenomic surveillance of pathogen and antimicrobial resistance gene transmission in hospitalized neonatesK23AI185326 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHU, VICTORIA TIEN-YU · 2024 to 2025
$395k
CIHR PJT-156214McMaster University David Braley Chair in Computational BiologyNHLBI NIH HHS R01 HL155418NIAID NIH HHS K23 AI185326NIH/NHLBI 5R01HL155418
6 · The paper itself

Abstract

backgroundAntimicrobial resistant (AMR) pathogens represent urgent threats to human health, and their surveillance is of paramount importance. Metagenomic next-generation sequencing (mNGS) has revolutionized such efforts, but remains challenging due to the lack of open-access bioinformatics tools capable of simultaneously analyzing both microbial and AMR gene sequences.

resultsTo address this need, we developed the Chan Zuckerberg ID (CZ ID) AMR module, an open-access, cloud-based workflow designed to integrate detection of both microbes and AMR genes in mNGS and single-isolate whole-genome sequencing (WGS) data. It leverages the Comprehensive Antibiotic Resistance Database and associated Resistance Gene Identifier software, and works synergistically with the CZ ID short-read mNGS module to enable broad detection of both microbes and AMR genes from Illumina data. We highlight diverse applications of the AMR module through analysis of both publicly available and newly generated mNGS and single-isolate WGS data from four clinical cohort studies and an environmental surveillance project. Through genomic investigations of bacterial sepsis and pneumonia cases, hospital outbreaks, and wastewater surveillance data, we gain a deeper understanding of infectious agents and their resistomes, highlighting the value of integrating microbial identification and AMR profiling for both research and public health. We leverage additional functionalities of the CZ ID mNGS platform to couple resistome profiling with the assessment of phylogenetic relationships between nosocomial pathogens, and further demonstrate the potential to capture the longitudinal dynamics of pathogen and AMR genes in hospital acquired bacterial infections.

conclusionsIn sum, the new AMR module advances the capabilities of the open-access CZ ID microbial bioinformatics platform by integrating pathogen detection and AMR profiling from mNGS and single-isolate WGS data. Its development represents an important step toward democratizing pathogen genomic analysis and supporting collaborative efforts to combat the growing threat of AMR.

Indexed as

BacteriaCloud ComputingDrug Resistance, BacterialAnti-Bacterial AgentsComputational BiologyHigh-Throughput Nucleotide SequencingHumansMetagenomicsSoftwareWhole Genome SequencingAnti-Bacterial AgentsAntimicrobial resistanceChan Zuckerberg IDCZ IDMetagenomicsWhole-genome sequencing

Identifiers

PMID40329334
PMCPMC12057172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.